Angiopoietin-2 in the perinatal period and the role of intrauterine growth restriction

References

• Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1160–9
   Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55–60
   PubMed Web of Science ®Google Scholar
• Valenzuela DM, Griffiths J, Rojas J, Aldrich TH, Jones PF, Zhou H, et al. Angiopoietin 3 and diverging gene counterparts in mouse and man. Proc Natl Acad Sci USA 1999; 96: 1904–9
   PubMed Web of Science ®Google Scholar
• Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–8
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389–95
   PubMed Web of Science ®Google Scholar
• Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998; 273: 18514–21
   PubMed Web of Science ®Google Scholar
• Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1 and angiopoietin-2. J Clin Endocrinol Metab 2002; 87: 4213–24
   PubMed Web of Science ®Google Scholar
• Jones PF. Not just angiogenesis – wider roles for the angiopoietins. J Pathol 2003; 201: 515–27
   PubMed Web of Science ®Google Scholar
• Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998; 83: 852–9
   PubMed Web of Science ®Google Scholar
• Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274: 15732–9
   PubMed Web of Science ®Google Scholar
• Yuan HT, Yang SP, Woolf AS. Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int 2000; 58: 1912–9
   PubMed Web of Science ®Google Scholar
• Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000; 156: 2077–89
   PubMed Web of Science ®Google Scholar
• Krikun G, Schatz F, Finlay T, Kadner S, Mesia A, Gerrets R, et al. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun 2000; 275: 159–63
   PubMed Web of Science ®Google Scholar
• Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification and etiology. Clin Obstet Gynecol 1992; 35: 99–107
   PubMed Web of Science ®Google Scholar
• Regnault TRH, Galan HL, Parker TA, Anthony RV. Placental development in normal and compromised pregnancies – a review. Placenta 2002; 23((Suppl A))S119–29
   PubMed Web of Science ®Google Scholar
• Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab Invest 1999; 79: 151–70
   PubMed Web of Science ®Google Scholar
• Gardosi J, Chang A, Kaylan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992; 339: 283–7
   PubMed Web of Science ®Google Scholar
• Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995; 6: 168–74
   PubMed Web of Science ®Google Scholar
• Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 1191–6
   PubMedGoogle Scholar
• Lyall F, Young A, Boswell F, Kingdom JC, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18: 269–76
   PubMed Web of Science ®Google Scholar
• Dunk C, Shams M, Nijjar S, Rhaman M, Qui Y, Bussolati B, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000; 156: 2185–99
   PubMed Web of Science ®Google Scholar
• Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 2002; 3: 411–23
   PubMed Web of Science ®Google Scholar